Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Por Philippen, Leonne E, Dirkx, Ellen, Wit, Jan B M, Burggraaf, Koos, de Windt, Leon J, da Costa Martins, Paula A
Publicado no Mol Ther (2015)

Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca(2+) release

Por Reynolds, Julia O., Quick, Ann P., Wang, Qiongling, Beavers, David L., Philippen, Leonne E., Showell, Jordan, Barreto-Torres, Giselle, Theurauf, Donna J., Doroudgar, Shirin, Glembotski, Christopher C., Wehrens, Xander H.T.
Publicado no Int J Cardiol (2016)

‘Striated Muscle Preferentially Expressed Protein Kinase’ (SPEG) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity

Por Quick, Ann P., Wang, Qiongling, Philippen, Leonne E., Barreto-Torres, Giselle, Chiang, David Y., Beavers, David, Wang, Guoliang, Khalid, Maha, Reynolds, Julia O., Campbell, Hannah M., Showell, Jordan, McCauley, Mark D., Scholten, Arjen, Wehrens, Xander H. T.
Publicado no Circ Res (2016)

Novel Junctophilin-2 Mutation A405S Is Associated With Basal Septal Hypertrophy and Diastolic Dysfunction

Por Quick, Ann P., Landstrom, Andrew P., Wang, Qiongling, Beavers, David L., Reynolds, Julia O., Barreto-Torres, Giselle, Tran, Viet, Showell, Jordan, Philippen, Leonne E., Morris, Shaine A., Skapura, Darlene, Bos, J. Martijn, Pedersen, Steen E., Pautler, Robia G., Ackerman, Michael J., Wehrens, Xander H.T.
Publicado no JACC Basic Transl Sci (2017)